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Abstract
Background—Although cancer research has advanced at a rapid pace, a gap remains between 
what is known about how to improve cancer prevention and control (CPC) and what is 
implemented as best practices within health care systems and communities. The Cancer Prevention 
and Control Research Network (CPCRN), with more than 10 years of dissemination and 
implementation research experience, aims to accelerate the uptake and use of evidence-based CPC 
interventions.
Methods—The collective work of the CPCRN has facilitated the analysis and categorization of 
research and implementation efforts according to the Interactive Systems Framework for 
Dissemination and Implementation (ISF), providing a useful heuristic for bridging the gap 
between prevention research and practice. The ISF authors have called for examples of its 
application as input to help refine the model.
Results—We provide examples of how the collaborative activities supported by the CPCRN, 
using community-engaged processes, accelerated the synthesis and translation of evidence, built 
both general and innovation-specific capacity, and worked with delivery systems to advance cancer 
control research and practice.
Conclusions—The work of the CPCRN has provided real-world examples of the application of 
the ISF and demonstrated that synthesizing and translating evidence can increase the potential that 
evidence-based CPC programs will be used and that capacity building for both the support system 
and the delivery system is crucial for the successful implementation and maintenance of evidence-
based cancer control.
Impact—Adoption and implementation of CPC can be enhanced by better understanding ISF 
systems and intervening to improve them.
Introduction
Over the last decade, prevention research has advanced at a rapid pace. However, gaps still 
exist between what is known about how to improve health and what is implemented as best 
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practice within health care systems and communities (1–3). In the cancer prevention and 
control (CPC) field, these gaps will continue to widen if we do not improve our 
understanding of how and why evidence-based interventions (EBI) are adopted and 
implemented. Dissemination and implementation (D&I) science, which seeks to identify the 
best means of translating effective interventions into practice, is critical to closing the 
research-to-practice gap (4).
The Interactive Systems Framework for Dissemination and Implementation (ISF; Fig. 1) 
provides a useful heuristic to guide the growing field of D&I research and practice (5). 
Three systems comprise the ISF and must work together to effectively move research to 
practice. The first system, Prevention Synthesis and Translation, summarizes existing 
evidence and customizes evidence-based products to be more easily accessible and usable by 
end users. The second system, Prevention Support, provides general and intervention-
specific training, technical assistance, and tools to build practitioner and organizational 
capacity to implement EBIs. The third system, Prevention Delivery, executes activities to 
implement and deliver EBIs (5).
Using the ISF to better understand and intervene to accelerate the adoption, implementation 
and maintenance of CPC EBIs could result in improved means for translating the evidence, 
providing supportive structures for implementation, and building capacity for delivery. The 
synthesis and translation system (5) generates 2 different types of products—systematic 
review findings (e.g., Guide to Community Preventive Services; ref. 6) and intervention 
programs (e.g., Research Tested Intervention Programs; ref. 7). The challenge for 
practitioners is one of interpreting and applying research findings for use in community and 
practice settings (8). Much is needed to improve research synthesis and translation to 
accelerate the uptake and use of effective cancer control EBIs (9).
Within the framework of the ISF, the Rapid Synthesis and Translation Process (RSTP) 
supports the work of organizations that are tasked with presenting the best available science 
that can be easily and quickly understood (10). The RSTP provides guiding questions, action 
steps, and process components that can accelerate the work of organizations that are 
strategically positioned to bridge the gap between the research and practice realms (10). 
Noonan and colleagues have suggested a new focus on marketing and communications to 
ensure that research innovations being "pushed" to the public correspond to the needs of end 
users and that there is sufficient "pull" from end users to justify the provision of these 
specific innovations (11).
The support and delivery systems also require specific interventions to increase general and 
innovation-specific capacity to carry out prevention efforts (5, 9, 12). Following the 
development of the ISF, Wandersman and colleagues proposed an evidence-based system for 
innovation support (EBSIS) to increase the effectiveness and efficiency of support activities 
(13). The EBSIS model is conceptualized as a bridge between the ISF Prevention Support 
and Delivery Systems and is intended to build capacity for implementation (14, 15). EBSIS 
includes 4 components for innovation-specific and general capacity-building: tools, training, 
technical assistance, and quality assurance/quality improvement (16).
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Researchers, health care leaders, and other stakeholders can use the ISF framework (10, 13, 
16) to better understand system resources and challenges and to identify opportunities to 
accelerate EBI use. However, there are few examples of its application, particularly in the 
area of cancer control. ISF developers note that learning from stakeholders’ experience of 
processes described in the ISF is essential to further refine and expand the ISF and better 
understand interactions between systems (5). This article describes how the Cancer 
Prevention and Control Research Network (CPCRN) has conducted dissemination and 
implementation research and practice across the 3 systems of the ISF. We apply the ISF 
retrospectively, providing specific examples of activities within these systems. We also 
identify challenges and opportunities to work both within and across these systems to 
enhance dissemination and implementation of EBIs for cancer control.
Description of the CPCRN
The CPCRN is a national network funded by the National Center for Chronic Disease 
Prevention and Health Promotion at the Centers for Disease Control and Prevention (CDC) 
and the Division of Cancer Control & Population Sciences of the National Cancer Institute 
(NCI). The mission of CPCRN is to accelerate the use of EBIs in communities and to fill the 
evidence gaps about "what works" in CPC (17). The CPCRN is a unique "network of 
networks" composed of 10 centers in 9 states, each with their own local network of partners. 
CPCRN history is described elsewhere (17, 18). Table 1 highlights the activities of 
CPCRN’s 5 workgroups and how they address different ISF components.
Results
Prevention synthesis and translation system
CPCRN’s role in synthesizing evidence—CPCRN members update and synthesize 
existing evidence and conduct environmental scans of implementation efforts to add 
practice-based perspectives to existing evidence. For example, faculty from 6 CPCRN 
centers joined experts from the CDC, NCI, academic institutions, and the U.S. Preventive 
Services Task Force to review evidence on effective interventions to increase breast, 
cervical, and colorectal cancer screening and to update recommendations in the Guide to 
Community Preventive Services (Community Guide; ref. 19). The multidisciplinary team 
ensured that the final product was scientifically accurate and relevant to end users. Currently, 
another cross-site CPCRN team [University of Texas Health Science Center at Houston 
(UTH), Houston, TX; Emory University, Atlanta, GA; University of California at Los 
Angeles (UCLA), Los Angeles, CA; University of South Carolina (USC), Columbia, SC; 
and University of Washington (UW), Seattle, WA] is helping to reexamine the evidence and 
update Community Guide recommendations for multicomponent cancer screening 
interventions.
Special events (e.g., health fairs, screening events) are a common CPC activity (20); 
however, evidence is lacking on whether they increase cancer screening rates (21). Led by 
Emory, the CPCRN synthesized practice and research-based evidence on the effectiveness of 
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special events via a systematic review of peer-reviewed and gray literature (20). Emory is 
conducting a prospective study with UTH and CBOs across the country on the effectiveness 
and cost-effectiveness of health fairs to promote breast, cervical, and colorectal cancer 
screening.
University of Colorado (UC; Denver, CO), Texas A&M (College Station, TX), UW, and 
Harvard University (Cambridge, MA) CPCRNs conducted an environmental scan of health 
promotion activities for cancer survivors to better understand the extent to which research 
about recommended lifestyle behaviors and pyschosocial support is translated into practice. 
The results of this pragmatic synthesis showing that few programs provided comprehensive 
health promotion services will be used to inform future program planning and evaluations 
and help providers and survivors locate different types of health promotion programs (22)
CPCRN’s role in translating existing evidence—CPCRN’s role in translating 
evidence has included activities and products that make the findings from evidence 
syntheses easier to adopt and implement (23). For example, Washington University (St. 
Louis, MO) CPCRN partnered with CDC’s Colorectal Cancer Control Program (CRCCP) to 
assess and increase use of 2 evidence-based interventions—small media and client 
reminders—for promoting CRC screening among CRCCP grantees and partners in 25 states 
and 4 tribal organizations (24). Researchers developed an online tool (MIYO or Make It 
Your Own; www.MIYOworks.org) to help users customize these Community Guide–
recommended interventions for the specific populations they serve (25, 26). Registered users 
from 370 state and local health organizations in 47 states have created more than 4,300 
versions of EBIs through MIYO, with a particular focus on vulnerable populations (27). The 
use of MIYO for promoting colorectal cancer screening has led CDC to invest in developing 
new MIYO modules promoting breast and cervical cancer screening.
The UCLA and Texas A&M CPCRNs successfully translated the evidence-based Stanford 
Chronic Disease Self-Management Program for use among cancer survivors by taking a 
generic chronic disease self-management program and adding components that are 
especially relevant to cancer survivors’ increased attention to symptom management, 
making informed treatment decisions, and improving lifestyle behaviors (28). More than 25 
workshops were provided to 244 participants. More than 80% of participants attended >3 of 
the 6 sessions, 95% of the participants were satisfied and would recommend the program 
(28, 29).
Prevention support system
The CPCRN conducts both the general and innovation-specific capacity-building functions 
of the prevention support system (PSS). Several examples of these CPCRN activities also fit 
into the 4 EBSIS components: tools, training, technical assistance, and quality assurance/
quality improvement, as described by Wandersman and colleagues. EBSIS uses the Getting 
to Outcomes (GTO) framework, a 10-step approach to aid the identification and synthesis of 
concepts, tools, and evidence (13). These include assessment, planning, addressing capacity 
issues, implementing, evaluation, continuous quality improvement, and addressing 
sustainability issues.
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General capacity building—CPCRN researchers assess delivery system capacity, as in 
GTO Step 1, and then design and provide training and technical assistance to address gaps. 
For example, the CPCRN conducted a survey of 282 cancer control planners from 7 states to 
understand their knowledge, attitudes, behaviors, and training needs for translating research 
evidence into practice (9, 13). Fewer than half of respondents (48%) representing 
government agencies, health care providers, and community-based organizations had ever 
used online resources to locate EBIs for CPC (9). Most expressed a need for training on how 
to locate and secure funding and technical assistance and how to adapt EBIs for different 
populations (75.8% and 64.2%, respectively; ref. 9). Results of this assessment led to 2 
major CPCRN-wide initiatives to provide guidance to partners on finding, adapting, and 
implementing EBIs.
Consistent with the training component of EBSIS, the Capacity Building and Technical 
Assistance Training (CBTAT) Workgroup produced a uniform set of training materials to 
increase community capacity to use EBIs (26). The training familiarizes clinical and 
community partners with credible sources of EBIs (e.g., Community Guide, Cancer Control 
P.L.A.N.E.T.) that describe evidence about what works in CPC practice. The CBTAT group 
conducted multiple trainings at national conferences and for partners such as state health 
departments, the National Breast and Cervical Cancer Early Detection Program, and the 
National Association of Chronic Disease Directors. Feedback from our partners made it 
clear that simply telling them where to find EBIs was insufficient to prompt use (9, 26, 30). 
They wanted to learn how to choose from among recommended strategies, adapt EBIs to fit 
specific settings and audiences, and estimate the costs of implementation and maintenance 
(30). An evaluation of 3 revised trainings conducted in Georgia that addressed these needs 
found that competencies related to locating evidence-based resources and defining steps in 
the adaptation process, along with specific guidance on adaptation and implementation, 
increased capacity among community practitioners who attended the trainings (30).
With funds from an NCI R01 (CA163526-01), CPCRNs (led by UTH and Emory) are 
developing and evaluating Tailored Aid for Communities Adapting Tested Interventions for 
Cancer Control (TACTICC; ref. 31), an online tool to walk users through the steps of finding 
and adapting EBIs for CPC, an example of the tools component of EBSIS.
The CPCRN has also studied what factors influence adoption and implementation of CPC in 
Community Health Centers (CHC) conducting a survey of CHCs in seven states. This study 
resulted in the development and validation of measures of inner-setting constructs as defined 
by the Consolidated Framework for Implementation Research (CFIR) that can be used to 
identify areas in need of general capacity building (32). Another study based on these data 
demonstrated that clinic Practice Adaptive Reserve was significantly associated with 
implementation of colorectal cancer screening programs at CHCs (33). Adaptive reserve 
includes relationships, leadership, time for group reflection and consideration about changes, 
and attention to the environment (34). The CPCRN Federally Qualified Health Center 
(FQHC) workgroup also conducted in-depth interviews with 59 leaders and staff from more 
than 25 FQHCs across the country to better understand factors that influence 
implementation of EBIs in FQHCs or similar settings (35). Collectively, these studies 
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identify factors influencing implementation that can be targeted to accelerate and maintain 
CPC EBI use.
Intervention-specific capacity building—CPCRN teams also provide training and 
other support to build capacity to adapt and implement specific EBIs or guidelines while 
maintaining fidelity to a program’s core elements. Specific EBIs include Pool Cool, Body & 
Soul, Treatwell 5-a-Day programs, Friend to Friend, and the Community Guide breast 
cancer screening recommendations (Emory and Wash U, Wash U, UW, Texas A&M, and 
UNC respectively; refs. 36–39). These initiatives have increased EBI adoption and 
implementation. UNC, for example, found that CBOs increased their adoption of 
Community Guide EBIs following training and technical assistance, with close to twice as 
many applicants proposing to do one-to-one education and/or client reminders (13). UTH 
worked with community organizations in both Houston and Puerto Rico to adapt and 
implement Cultivando la Salud, an evidence-based breast and cervical cancer screening 
program. In Houston, the adapted program increased both mammography and Pap test 
screening. Preliminary results indicate that 35.0% and 37% of women in the intervention 
group received mammography and Pap test screening, respectively, representing a level two 
a half times greater than women in the comparison group (40). In Puerto Rico, the adapted 
CLS program similarly increased Pap test screening [OR, 2.34; 95% confidence interval 
(CI), 1.13–4.87] but not mammography (41).
CPCRN researchers from Emory, UTH, Texas A&M, UCLA, and USC have instituted 
minigrant programs (ranging from $3,500–$12,000/participating organization) as another 
approach to supporting CBOs’ implementation of specific EBIs that have proven to be 
effective at changing diet, physical activity, and screening behaviors (37, 39, 42, 43). The 
training and technical assistance offered typically focused on several of the GTO steps, 
including goal setting, addressing capacity, planning, implementing, and evaluating. 
Consequently, the training and technical assistance enabled funded sites to adapt EBIs to 
better suit their setting and audience, overcome systems barriers to implementation, evaluate 
their programs, and apply for additional funding (39).
The capacity to adopt and implement specific guidelines such as the use of patient-reported 
measures in primary care is another area recently advanced by the CPCRN. The UCLA 
CPCRN piloted a tool using a set of validated patient-reported measures of health behaviors 
and psychosocial issues (44, 45) in 5 FQHCs serving primarily Latino and Asian patients. 
They found that it was feasible to implement the tool in clinic settings and showed high 
levels of patient, staff, and physician acceptance and perceived use for facilitating patient–
physician discussions.
Following this, a national multisite pragmatic trial was launched, using a publicly available 
tool for electronic capture and interpretation of the measures (www.myownhealthreport.org), 
to assess the feasibility and use of incorporating the measures into routine primary care 
practice. Four CPCRN sites (UCLA, UNC, UTH, Texas A&M) participated in the trial, 
which confirmed findings of the pilot study. Preliminary findings indicate that intervention 
patients reported significantly more positive changes in diet, physical activity, and other 
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areas (45, 46). This example incorporates all EBSIS components: tools, training, technical 
assistance, and quality improvement.
These experiences helped the CPCRN better understand the types of adaptations 
practitioners make to EBIs (39), the challenges of finding and adapting EBIs, and the types 
and intensity of technical assistance needed at various stages in the process of moving EBIs 
into community and clinical settings.
Prevention delivery system
Understanding the delivery systems’ current use of EBIs—All CPCRN sites 
engage local delivery systems in research–practice partnerships to improve CPC. For 
example, the CPCRN is collaborating with the CDC to evaluate CRCCP grantees’ 
implementation of 5 Community Guide EBIs and patient navigation (47). The CPCRN 
surveys CRCCP grantees annually to assess EBI use. Survey data show that grantees are 
more likely to implement small media and client reminders than provider-oriented EBIs (48) 
and are more likely to implement all of the Community Guide EBIs than states and tribal 
groups that do not have CRCCP funding (48, 49).
Partnering with delivery systems to improve CPC—The CPCRN builds 
partnerships with organizations to expand traditional prevention delivery settings and extend 
the reach of effective interventions (50, 51) in varied settings, including workplaces, faith-
based organizations, housing developments, the 2-1-1 Helpline, and community health 
centers.
Workplaces are an important delivery system given that 63% of U.S. adults are employed 
(52). UW’s CPCRN partnered with the American Cancer Society to develop Workplace 
Solutions, a package of Community Guide EBIs that offers employers free, on-site 
consultation to help them select, adapt, and implement EBIs (53, 54). ACS delivered 
Workplace Solutions to more than 1,700 employers across the United States (55). Harvard’s 
CPCRN is developing a tailored, telephone-delivered intervention promoting smoking 
cessation and weight management among blue-collar workers through health and welfare 
funds (56). UCLA is disseminating an organizational change physical activity and healthy 
nutrition intervention in worksites throughout Los Angeles County. Texas A&M is working 
with academic, health care, and business workplaces to promote successful application of 
the CEO Cancer Gold Standard. USC offers members of African-American communities of 
faith diet, physical activity, and stress reduction interventions along the lines of a 
randomized trial conducted in African–American churches in central South Carolina. This 
work, which has been shown to be effective at modulating C-reactive protein, an important 
marker of systemic inflammation, is moving to D&I phase with funding from the NHLBI 
(R01-HL122285; ref. 57). It also complements USC’s pilot project—creating a farmers’ 
market at an FQHC (58–60), which has since formed the basis of the interinstitutional 
collaborative effort in 3 states—Ohio, South Carolina, and Texas (61).
Several CPCRNs (Wash U, UTH, UNC, Emory, UCLA) are partnering with local 2-1-1 
Helplines, a national 3-digit telephone information and referral service connecting people to 
local health and social services (62). 2-1-1 callers are often racial or ethnic minorities with 
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lower levels of income and education than the general population and higher rates of 
unemployment or job insecurity (63). The CPCRN formed a 2-1-1 Workgroup to address 
research questions posed by 2-1-1 and participated in a nationwide research consortium with 
academics and 2-1-1 partners. Progress and contributions are highlighted in a Supplement to 
the American Journal of Preventive Medicine (64).
The CPCRN found that 2-1-1 callers were willing to complete a brief cancer risk assessment 
after receiving standard 2-1-1 service and would accept cancer control referrals when 
offered (63). CPCRN researchers also (65–68) demonstrated that 2-1-1 callers had 
significantly higher rates of smoking and lower rates of screening for breast, cervical, and 
colorectal cancers than U.S. adults. WU’s CPCRN conducted a randomized controlled trial 
that demonstrated the efficacy of using proactive referrals and navigators for preventive 
services to motivate callers to follow-up with cancer control needs (69). UTH’s CPCRN is 
currently implementing and evaluating navigation services and referrals for preventive 
services for 2-1-1 Texas callers (67). In collaboration with 3 other CPCRNs (WU, UTH, 
UNC), Emory received NCI funding (S713745/U101CA154282) to test an intervention to 
promote smoke-free homes with an efficacy trial followed by 2 effectiveness trials in which 
the intervention will be delivered by 2-1-1 North Carolina and Houston. Results from a pilot 
study of the intervention showed that more than 30% of households had established a 
smoke-free home at follow-up (70). The intervention, if effective, will be disseminated to 
2-1-1s nationally through a grants program.
Discussion
The research described in this article advances the field of implementation science in several 
ways. First, it operationalizes definitions and descriptions of the ISF and validates its 
usefulness as a way of categorizing activities and studies that contribute to enhancing 
research translation. Second, it demonstrates the strength of national collaborative efforts 
focused on a common theme and informed by experiences with local partnerships. Finally, 
the framework allowed CPCRN researchers to better conceptualize key systems, functions, 
and relationships affecting the movement of research into practice. The CPCRN works in 
and across all 3 ISF systems and provides insight into an understudied element of the ISF: 
the potential of bidirectional communication across systems (see Fig. 1) and their respective 
stakeholders (e.g., funders, researchers, practitioners, consumers; ref. 13). Each CPCRN 
engaged partners to develop local CPC delivery systems and have worked in cross-site 
collaborative partnerships to develop national partnerships. These partnerships helped 
CPCRN researchers identify delivery system needs, which in turn, led to the creation of 
tools and other supports, such as the MIYO system that delivery systems could use to 
accelerate appropriate EBI use. Interactions with the delivery system also led to new 
syntheses of evidence that are then translated into recommendations for practice. For 
example, CPCRN’s evaluation of CDC’s NBCCEDP led to a research project to evaluate the 
effectiveness of health fairs and other special events, a common strategy used by grantees 
yet not supported by research findings. By working closely with members of the Delivery 
System, the CPCRN reshaped its research agenda to produce evidence to support current 
CPC efforts as well as foster more effective use of special events across settings.
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The exchange across ISF systems is bidirectional (see Fig. 1) in that CPCRN researchers not 
only learn from the delivery system but also provide trainings and technical assistance to 
build delivery system capacity to select and implement EBIs. The network’s community-
engaged partnerships and resulting exchanges such as those with partners, including 
community health centers, the CRCCP, and others, allowed the CPCRN to consider a variety 
of perspectives when synthesizing and translating evidence and creating tools, trainings, and 
other strategies to support the use of evidence in CPC practice. In addition, the success of 
the CPCRN can also be attributed to funder engagement that supported collaborative efforts 
and provided resources for network infrastructure. Rhoades and colleagues have proposed 
the need to actively engage funders in the process of dissemination and implementation and 
to support the transfer of bidirectional knowledge between each of the systems (Fig. 1; ref. 
71).
The TACTICC project enhances interactions between the Prevention Support and Delivery 
Systems. It makes the steps of finding and adapting EBIs explicit and guides CBOs through 
the process of mapping the needs of the community and using that information to 
systematically adapt the EBI. Members of the Delivery System receive concrete guidance 
and materials to use during implementation and to increase the likelihood that the adapted 
EBI will appropriate for the community and setting.
The need to advance D&I science and to use what we learn to effectively move CPC 
evidence into real-world settings is particularly relevant in the current practice and policy 
environment. Provisions within the Affordable Care Act (ACA) provide the opportunity to 
investigate new approaches for disseminating information and implementing CPC practices 
that will benefit traditionally underserved populations (72). The ACA will change the types 
of actors and design of delivery systems, and practitioners will require ongoing support to 
adapt to these changes (73). Networks such as the CPCRN can play a central role by 
synthesizing and translating evidence and building the new types of capacity the delivery 
system will need to provide and evaluate CPC care within an evolving context (74).
The CPCRN experience shows that the ISF Systems are relevant and useful and confirms 
that developing research–practitioner–funder–consumer partnerships (13) leads to an 
acceleration of knowledge creation around the Prevention Support System. In addition, 
while resources exist that synthesize evidence on CPC and describe effective programs, they 
may be of little use to community partners without training and technical assistance by 
researchers, academic partners, program developers, and others. As exemplified by CPCRN 
activities, strengthening ties between translation, synthesis, and support activities can help 
practitioners benefit from these resources and ultimately be better equipped to adopt and 
implement evidence-based approaches for cancer control. Future prospective investigations 
of the ISF as part of real-world program planning, implementation, and evaluation efforts 
would add to our understanding of how to apply the ISF to maximize EBP use. Nevertheless, 
the CPCRN’s experience is a testament to how concepts proposed in the ISF can lead to 
increased use of EBIs to address health disparities around chronic diseases such as cancer.
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The CPCRN is a dynamic network bringing together stakeholders from the ISF Systems to 
advance CPC innovations and evidence. The CPCRN takes a community-centered approach 
to ensure that its efforts to bridge the research-to-practice gap around CPC are grounded in 
the needs of community partners to build the evidence base and enhance their capacity to 
adopt, implement, and maintain effective interventions over time. We recognize that 
researchers, practitioners, and community members interested in advancing CPC cannot 
function in separate silos; instead, researchers must invite practitioners and community 
members to become intimately involved in the entire research process from program 
development to dissemination if they are to develop relevant and usable products.
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Table 1
Description, membership, and ISF systems addressed within CPCRN workgroups
Workgroup Description CPCRN members ISF system(s) addressed
FQHC • To develop and implement a quantitative and qualitative 
survey of FQHCs that belong to their state primary health 
care association. The survey addresses organizational 
factors that influence implementation of evidence-based 
cancer screening interventions in health center settings.
Emory, Texas A&M, UC, 
UCLA, UNC, USC, UTH, 
UW, Wash U








• To build the capacity of cancer control planners and 
public health professionals to locate, select, adopt, adapt, 
implement, and evaluate evidence-based cancer 
prevention programs, policies, and practices through face-
to-face training and technical assistance.
Emory, Texas A&M, UC, 
Harvard, UCLA, UNC, 
USC, UTH, UW, Wash U
Prevention synthesis and 
translation; Prevention 
support: intervention-specific 
and general capacity building; 
prevention delivery
• To develop a training curriculum on using cancer 
evidence with slides, interactive exercises, and resources 
for cancer planners, which has been delivered at national 
conferences and to local community partners.
• To research capacity-building models and evaluate 
training or technical assistance initiatives to translate 
evidence-based approaches into communities.
2-1-1 • To form research delivery partnerships with 2-1-1 call 
centers nationwide to conduct cancer screening, 
vaccination, and smoking interventions. 2-1-1 is a 
nationally designated 3-digit telephone exchange that 
links underserved callers to health and social services in 
their community.
Emory, Texas A&M, 
UCLA, UNC, USC, Wash 
U
Prevention support; prevention 
delivery
Survivorship • To investigate factors affecting cancer survivorship and 
strategies for improving long-term health outcomes of 
patients with cancer.
Emory, Texas A&M, UC, 
UCLA, UNC, USC, UTH, 
UW
Prevention synthesis and 
translation; prevention support
• To examine the best way to translate recently issued 
guidelines on elements that should be included in cancer 
survivorship care planning activities into action. To assess 
the effectiveness and dissemination of these efforts.
CRCCP EBI use • The CDC funded 29 states and tribes to increase 
colorectal cancer screening rates to 80% of age-eligible 
patients by 2014. This workgroup measures CRCCP 
grantees' adoption and implementation of the Community 
Guide's recommended strategies to increase colorectal 
cancer screening. These strategies include client 
reminders, small media, reducing structural barriers, 
provider assessment and feedback, and provider 
reminders and recall.
Emory, Harvard, UC, 
UCLA, UNC, USC, UTH, 
Wash U, UW
Prevention synthesis and 
translation; prevention 
delivery
• To create survey measures adaptable to other studies and 
settings attempting to study the implementation process.
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